Beclomethasone nasal Pregnancy and Breastfeeding Warnings
Brand names: Beconase AQ, QNASL, Vancenase AQ, Vancenase AQ DS
Medically reviewed by Drugs.com. Last updated on Jun 5, 2023.
Beclomethasone nasal Pregnancy Warnings
Benefit should outweigh risk
US FDA pregnancy category: C
Comments:
-Hypoadrenalism may occur in infants born of mothers taking corticosteroids during pregnancy.
-These infants should be carefully monitored.
Animal studies have shown that subcutaneous administration produced fetal toxicity. There are no adequate and well-controlled studies in pregnant women on the teratogenic effects from this drug.
US FDA pregnancy category C: Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks.
Beclomethasone nasal Breastfeeding Warnings
Benefit should outweigh risk
Excreted into human milk: Unknown
Excreted into animal milk: Data not available
Comments: At therapeutic doses minimal effects are expected.
See also
References for pregnancy information
- Cerner Multum, Inc. "UK Summary of Product Characteristics."
- Cerner Multum, Inc. "Australian Product Information."
- (2015) "Product Information. Qnasl (beclomethasone nasal)." Teva Pharmaceuticals USA
- (2015) "Product Information. Beconase AQ (beclomethasone nasal)." GlaxoSmithKline
References for breastfeeding information
- Cerner Multum, Inc. "UK Summary of Product Characteristics."
- Cerner Multum, Inc. "Australian Product Information."
- (2015) "Product Information. Qnasl (beclomethasone nasal)." Teva Pharmaceuticals USA
- (2015) "Product Information. Beconase AQ (beclomethasone nasal)." GlaxoSmithKline
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
